Xencor, Inc Operating Leases, Future Minimum Payments, Due in Two Years
Xencor, Inc (XNCR) had Operating Leases, Future Minimum Payments, Due in Two Years of $2.40 million as of 2018-12-31, per its 10-K filed 2019-02-26.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears · last filed 2019-02-26
- 2018-12-31: Operating Leases, Future Minimum Payments, Due in Two Years $2.40M.
- 2018-09-30: Operating Leases, Future Minimum Payments, Due in Two Years $2.75M.
- 2018-06-30: Operating Leases, Future Minimum Payments, Due in Two Years $2.75M.
- 2018-03-31: Operating Leases, Future Minimum Payments, Due in Two Years $2.73M.
| Period end | Operating Leases, Future Minimum Payments, Due in Two Years |
|---|---|
| 2018-12-31 | $2.40M 10-K · filed 2019-02-26 |
| 2018-09-30 | $2.75M 10-Q · filed 2018-11-05 |
| 2018-06-30 | $2.75M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $2.73M 10-Q · filed 2018-05-07 |
| 2017-12-31 | $2.73M 10-K · filed 2018-02-28 |
| 2017-09-30 | $2.55M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $2.55M 10-Q · filed 2017-08-07 |
| 2017-03-31 | $833.00K 10-Q · filed 2017-05-10 |
| 2016-12-31 | $833.00K 10-K · filed 2017-03-01 |
| 2016-09-30 | $807.00K 10-Q · filed 2016-11-02 |
| 2016-06-30 | $807.00K 10-Q · filed 2016-08-03 |
| 2016-03-31 | $699.00K 10-Q · filed 2016-05-02 |
| 2015-12-31 | $699.00K 10-K · filed 2016-03-08 |
| 2015-09-30 | $679.00K 10-Q · filed 2015-11-04 |
| 2015-06-30 | $679.00K 10-Q · filed 2015-08-05 |
| 2015-03-31 | $679.00K 10-Q · filed 2015-05-05 |
| 2014-12-31 | $598.00K 10-K · filed 2015-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |